Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.

Buchacz K, Baker RK, Palella FJ Jr, Shaw L, Patel P, Lichtenstein KA, Chmiel JS, Vellozzi C, Debes R, Henry K, Overton ET, Bush TJ, Tedaldi E, Carpenter C, Mayer KH, Brooks JT; HIV Outpatient Study Investigators.

Antivir Ther. 2013;18(1):65-75. doi: 10.3851/IMP2450. Epub 2012 Oct 30.

PMID:
23111762
2.

The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.

Julius H, Basu D, Ricci E, Wing J, Basu JK, Pocaterra D, Bonfanti P.

Curr HIV Res. 2011 Jun;9(4):247-52. doi: 10.2174/157016211796320360.

PMID:
21631427
3.
4.

Comparison of demographic characteristics and upper gastrointestinal endoscopy findings in HIV-positive, antiretroviral-treated patients with and without Helicobacter pylori coinfection.

Nkuize M, De Wit S, Muls V, Ntounda R, Gomez-Galdon M, Buset M.

Helicobacter. 2012 Apr;17(2):153-9. doi: 10.1111/j.1523-5378.2011.00929.x.

PMID:
22404447
5.

Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy.

Baekken M, Os I, Sandvik L, Oektedalen O.

J Hypertens. 2008 Nov;26(11):2126-33. doi: 10.1097/HJH.0b013e32830ef5fb.

PMID:
18854751
6.

Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.

Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT.

AIDS. 2006 May 12;20(8):1171-9.

PMID:
16691069
7.

Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C.

Farley J, Gona P, Crain M, Cervia J, Oleske J, Seage G, Lindsey J; Pediatric AIDS Clinical Trials Group Study 219C Team.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):480-7.

PMID:
15764965
8.
9.

Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.

Sagoe KW, Agyei AA, Ziga F, Lartey M, Adiku TK, Seshi M, Arens MQ, Mingle JA.

J Med Virol. 2012 Jan;84(1):6-10. doi: 10.1002/jmv.22262.

PMID:
22095533
10.

Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients.

Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, Saag M.

HIV Med. 2010 Aug;11(7):462-8. doi: 10.1111/j.1468-1293.2009.00815.x. Epub 2010 Feb 15.

11.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
12.

Premature age-related comorbidities among HIV-infected persons compared with the general population.

Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F.

Clin Infect Dis. 2011 Dec;53(11):1120-6. doi: 10.1093/cid/cir627. Epub 2011 Oct 13.

PMID:
21998278
13.

A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.

Amorosa V, Synnestvedt M, Gross R, Friedman H, MacGregor RR, Gudonis D, Frank I, Tebas P.

J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):557-61.

PMID:
16044007
14.

Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.

Gardner LI, Klein RS, Szczech LA, Phelps RM, Tashima K, Rompalo AM, Schuman P, Sadek RF, Tong TC, Greenberg A, Holmberg SD; HIV Epidemiology Research Study Group.

J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):320-30.

PMID:
14600579
15.

Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007.

Spradling PR, Richardson JT, Buchacz K, Moorman AC, Brooks JT; HIV Outpatient Study (HOPS) Investigators.

J Viral Hepat. 2010 Dec;17(12):879-86. doi: 10.1111/j.1365-2893.2009.01249.x.

PMID:
20158604
16.

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group.

Arch Intern Med. 2002 Oct 14;162(18):2125-32.

PMID:
12374521
17.

Cystatin C and baseline renal function among HIV-infected persons in the SUN Study.

Overton ET, Patel P, Mondy K, Bush T, Conley L, Rhame F, Kojic EM, Hammer J, Henry K, Brooks JT; Sun Study Investigators.

AIDS Res Hum Retroviruses. 2012 Feb;28(2):148-55. doi: 10.1089/AID.2011.0018. Epub 2011 May 25.

PMID:
21480819
18.

Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults.

Tripathi A, Liese AD, Winniford MD, Jerrell JM, Albrecht H, Rizvi AA, Zhang J, Duffus WA.

Clin Cardiol. 2014 Sep;37(9):517-22. doi: 10.1002/clc.22311.

19.

Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.

Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, Gray KM, Cohen SM, Mermin J, Skarbinski J.

JAMA Intern Med. 2013 Jul 22;173(14):1337-44. doi: 10.1001/jamainternmed.2013.6841.

PMID:
23780395
20.

Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children.

Gaughan DM, Mofenson LM, Hughes MD, Seage GR 3rd, Ciupak GL, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Team.

Pediatrics. 2002 May;109(5):E74-4.

PMID:
11986480

Supplemental Content

Support Center